Showing 1 - 20 results of 78 for search '"HAART"', query time: 0.05s Refine Results
  1. 1

    Genetic Markers Associated to Dyslipidemia in HIV-Infected Individuals on HAART by Rosmeri K. Lazzaretti, Aline S. Gasparotto, Marina G. de M. Sassi, Carísi A. Polanczyk, Regina Kuhmmer, Jussara M. Silveira, Rossana P. Basso, Cezar A. T. Pinheiro, Mariângela F. Silveira, Eduardo Sprinz, Vanessa S. Mattevi

    Published 2013-01-01
    “…Due to the relatively high number of carriers of these risk variants, studies to verify treatment implications of genotyping before HAART initiation may be advisable to guide the selection of an appropriate antiretroviral therapy regimen.…”
    Get full text
    Article
  2. 2
  3. 3

    Clinical Features, Treatment, and Outcome of HIV-Associated Immune Thrombocytopenia in the HAART Era by Kimberley L. S. Ambler, Linda M. Vickars, Chantal S. Leger, Lynda M. Foltz, Julio S. G. Montaner, Marianne Harris, Viviane Dias Lima, Heather A. Leitch

    Published 2012-01-01
    “…The characteristics of HIV-associated ITP were documented prior to the HAART era, and the optimal treatment beyond HAART is unknown. …”
    Get full text
    Article
  4. 4
  5. 5

    Hospitalization due to Adverse Drug Reactions and Drug Interactions before and after HAART by Michelle M Foisy, Kevin Gough, Corinna M Quan, Kevin Harris, Dominique Ibanez, Anne Phillips

    Published 2000-01-01
    “…OBJECTIVE: To characterize and compare the rates of adverse drug reactions (ADRs) and interactions on admission in two, one-year periods: pre-highly active antiretroviral therapy (HAART) (phase 1) and post-HAART (phase 2).…”
    Get full text
    Article
  6. 6

    Fatal Disseminated Kaposi's Sarcoma due to Immune Reconstitution Inflammatory Syndrome following HAART Initiation by Fatuma Catherine Atieno Odongo

    Published 2013-01-01
    “…This is a case report of disseminated Kaposi's sarcoma in the context of immune reconstitution inflammatory syndrome in an HIV-infected patient on HAART regimen for 2 months. The patient rapidly progressed to death in 5 days after worsening pulmonary infiltrates and multiple organ failure.…”
    Get full text
    Article
  7. 7
  8. 8

    Factors Influencing Survival Status of HIV/AIDS after HAART in Huzhou City, Eastern China by Meihua Jin, Zhongrong Yang, Jing Li, Xiaoqi Liu, Zhenqian Wu

    Published 2022-01-01
    “…Highly active antiretroviral therapy (HAART) can effectively reduce the risk of death and opportunistic infections in patients with HIV/AIDS. …”
    Get full text
    Article
  9. 9

    Exploring survival rates in HIV-infected Ethiopian children receiving HAART: a retrospective cohort study by Yimam Getaneh, Yared Dejene, Birhanemeskel T. Adankie, Siti Qamariyah Khairunisa, Dominicus Husada, Kuntaman Kuntaman, Maria Inge Lusida

    Published 2025-01-01
    “…Background Studies have shown a high rate of mortality among adults despite the introduction of highly active antiretroviral therapy (HAART). However, long-term outcomes of HAART among children remain poorly documented in Ethiopia. …”
    Get full text
    Article
  10. 10

    Cryptococcal Meningitis: A Retrospective Cohort of a Brazilian Reference Hospital in the Post-HAART Era of Universal Access by Aline Z. de Azambuja, Gustavo Wissmann Neto, Guilherme Watte, Luciana Antoniolli, Luciano Z. Goldani

    Published 2018-01-01
    “…However, limited data exist for HIV-infected patients in the post-HAART (highly active antiretroviral therapy) era in Brazil. …”
    Get full text
    Article
  11. 11

    Limited restoration of T cell subset distribution and immune function in older people living with HIV-1 receiving HAART by Na Li, Hong-Yi Zheng, Wei Li, Xiao-Yan He, Mi Zhang, Xia Li, Ren-Rong Tian, Xing-Qi Dong, Zhi-Qiang Shen, Yong-Tang Zheng

    Published 2025-01-01
    “…Abstract Background Older people living with HIV-1 (PLWH) experience a dual burden from the combined effects of aging and HIV-1 infection, resulting in significant immune dysfunction. Despite receiving HAART, immune reconstitution is not fully optimized. …”
    Get full text
    Article
  12. 12
  13. 13
  14. 14

    Emergence of Exhausted B Cells in Asymptomatic HIV-1-Infected Patients Naïve for HAART is Related to Reduced Immune Surveillance by Manuela Fogli, Carlo Torti, Fabio Malacarne, Simona Fiorentini, Melania Albani, Ilaria Izzo, Cinzia Giagulli, Fabrizio Maggi, Giampiero Carosi, Arnaldo Caruso

    Published 2012-01-01
    “…B cells alteration was related to an increase in Torque teno virus (TTV) load, used as surrogate marker of immune function. Successfully HAART-treated patients showed normalization of B cell subpopulations frequency and TTV load. …”
    Get full text
    Article
  15. 15

    Serum Micronutrient Status of Haart-Naïve, HIV Infected Children in South Western Nigeria: A Case Controlled Study by H. C. Anyabolu, E. A. Adejuyigbe, O. O. Adeodu

    Published 2014-01-01
    “…We sought to determine the micronutrient status and associated factors of HAART-naïve HIV infected children and compare them with those of the HIV negative controls. …”
    Get full text
    Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20